Aquestive Therapeutics Inc (AQST) financials · rev $44.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Aquestive Therapeutics Inc (AQST) rev $44.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $44.5M | $57.6M |
| Cost of Revenue | $18.6M | $17.9M |
| Gross Profit | $26.0M | $39.7M |
| Operating Income | -$71.1M | -$30.8M |
| Net Income | -$83.8M | -$44.1M |
| EPS (Diluted) | -$0.78 | -$0.51 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $160.4M | $101.4M |
| Current Assets | $149.3M | $88.2M |
| Cash & Equivalents | $121.2M | $71.5M |
| Inventory | $6.17M | $6.04M |
| PP&E | $3.89M | $3.80M |
| Total Liabilities | $194.1M | $161.6M |
| Current Liabilities | $47.6M | $18.9M |
| Short-term Debt | $9.99M | N/A |
| Long-term Debt | $45.0M | $45.0M |
| Total Debt | $27.5M | $32.5M |
| Shareholders' Equity | -$33.7M | -$60.2M |
| Retained Earnings | -$447.0M | -$363.2M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$52.4M | -$35.8M |
| CapEx | $562.0K | $159.0K |
| Investing Cash Flow | -$562.0K | -$159.0K |
| Financing Cash Flow | $102.6M | $83.6M |
| Net Change in Cash | $49.6M | $47.7M |
| Free Cash Flow | -$53.0M | -$35.9M |
FAQ
What is AQST P/E and revenue?
Aquestive Therapeutics Inc (AQST) rev $44.5M.
What is AQST revenue?
Aquestive Therapeutics Inc last cached revenue is $44.5M (FY2025).
Is AQST profitable?
Aquestive Therapeutics Inc last cached net income is -$83.8M (FY2025).
What are AQST total assets?
Aquestive Therapeutics Inc last cached total assets are $160.4M (FY2025).
What is AQST free cash flow?
Aquestive Therapeutics Inc last cached free cash flow is -$53.0M (FY2025).
Not investment advice. Cached statements, not a live tape.